Stefan Früehauf

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee et al. · Blood · 2009 · 780 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

Julian Topaly, WJ Zeller, Stefan Früehauf · Leukemia · 2001 · 173 citations

Medicine, Oncology, Pharmacology +13

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Martin C. Müller, Norbert Gattermann, Tanja Lahaye et al. · Leukemia · 2003 · 126 citations

Medicine, Hematology, Oncology +12

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Stefan Früehauf, Marlon R. Veldwijk, Timon Seeger et al. · Cytotherapy · 2009 · 123 citations

Life Sciences, Hematology, Immunology +17

Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks

Marlon R. Veldwijk, Julian Topaly, Stephanie Laufs et al. · Molecular Therapy · 2002 · 108 citations · Full text

Life Sciences, Molecular Biology, Gene Therapy +12